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Abstract. The use of extemporal dosage form with pyroctone olamine in the complex treatment of patients with 
seborrheic dermatitis. Odintsova I.V., Diudiun A.D. The purpose of the work is to evaluate the efficacy and 
tolerance of extemporal dosage form with pyroctone olamine in the local treatment of patients with seborrheic 
dermatitis. Under our supervision there were 78 patients with seborrheic dermatitis aged 18 to 57 years. The average 
age of the patients was 29.5±2.1 years. Comprehensive treatment of patients with seborrheic dermatitis in both groups 
depended on the severity of clinical manifestations, the duration of the disease, and information on the effectiveness of 
previous therapy. For external treatment of the main group of patients with seborrheic dermatitis, an extemporaneously 
prepared gel with pyrocton olamine was used. Local treatment of patients in the comparison group consisted of the 
appointment of 1% cream of clotrimazole. An analysis of the results shows good therapeutic, microbiological 
effectiveness and good tolerance of extemporaneously prepared gel with pyrocton olamine in the complex treatment of 
patients with seborrheic dermatitis. The period for resolving the clinical manifestations of seborrheic dermatitis among 
patients in the main group was 2.5±0.1 days shorter compared with patients in the comparison group. The intensity of 
clinical manifestations in patients with seborrheic dermatitis of the main group decreased twice on the second day of 
complex treatment. In control patients with comparative seborrheic dermatitis, similar therapeutic efficacy was 
achieved on the fourth to fifth day. Long-term results of the study showed that the recurrence of the disease among 
patients of the main group was 5 (6.4%), and in patients of in the comparison group was 14 (17.9%). Clinical studies 
have shown good therapeutic efficacy and tolerance of the extemporal gel with pyroctone olamine in the complex 
treatment of patients with seborrheic dermatitis, which gives reason to recommend this dosage form for wider use in the 
practice of dermatovenerologists. 
 
Реферат. Застосування екcтемпоральної лікарської форми з піроктон оламіном у комплексному 
лікуванні хворих на себорейний дерматит. Одінцова І.В., Дюдюн А.Д. Мета роботи - дати оцінку 
ефективності та переносимості екстемпоральної лікарської форми з піроктон оламіном для місцевого 
лікування хворих на себорейний дерматит. Під нашим спостереженням знаходилися 78 хворих на себорейний 
дерматит у віці від 18 до 57 років. Середній вік пацієнтів становив 29,5±2,1 року. Комплексне лікування хворих 
на себорейний дерматит обох груп залежало від ступеня прояву клінічних симптомів, тривалості 
захворювання і відомостей про ефективність раніше проведеної терапії. Для зовнішнього лікування основної 
групи хворих на себорейний дерматит застосовували екстемпорально приготований гель з піроктон оламіном. 
Місцеве лікування хворих групи порівняння складалося з призначення 1% крему клотримазол. Аналіз отриманих 
результатів показує хорошу терапевтичну, мікробіологічну ефективність і хорошу переносимість екстем-
порально приготованого гелю з піроктон оламіном у комплексному лікуванні хворих на себорейний дерматит. 
Період розрішення клінічних проявів себорейного дерматиту серед хворих основної групи був на 2,5±0,1 дня 
коротше порівняно з хворими групи порівняння. Інтенсивність клінічних проявів у хворих на себорейний 
дерматит основної групи знизилась у два рази вже на другий день комплексного лікування. У хворих на 
себорейний дерматит порівняльної групи досягти подібної терапевтичної ефективності вдавалося на 
четвертий та п’ятий день. Віддалені результати проведеного дослідження показали, що рецидив захворю-
вання серед хворих основної групи  виник у 5 (6,4%), а серед пацієнтів групи порівняння – 14 (17,9%) пацієнтів. 
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Висновки. Клінічне дослідження показало хорошу терапевтичну ефективність і переносимість екстемпо-
рального гелю з піроктон оламіном у комплексному лікуванні хворих на себорейний дерматит, що дає підставу 
рекомендувати цю лікарську форму для більш широкого застосування в практиці лікарів-дерматовенерологів. 
 
Seborrheic dermatitis is one of the most common 
chronic inflammatory diseases, accompanied by a 
change in the quantitative and qualitative sebum 
composition, which contributes to the impairment of 
microbial landscape of skin and activity of saprophytic 
microorganisms. In seborrheic dermatitis the patho-
logical process in the form of erythematous-squamous 
rashes is localized on hairy part of the scalp and trunk 
which anatomically have a large number of sebaceous 
glands. The most frequent localization of the 
pathological process is the scalp, nasolabial folds, 
eyebrows, as well as skin of the chest and back. The 
seborrheic dermatitis incidence ranges from 1 to 3% of 
the total population and is diagnosed in more than 10% 
of dermatological patients [1, 6, 8, 14]. 
Clinical manifestations of seborrheic dermatitis 
are the appearance of well-defined erythematous-
squamous rashes mainly on the scalp, often accom-
panied by various subjective sensations. With the 
disease progression, the pathological process covers 
the entire hairy part to the border with smooth skin 
[1, 4, 5, 12]. 
The cause and development mechanisms of 
seborrheic dermatitis are multifaceted and not com-
pletely studied. In modern literature, such 
mechanisms of occurrence and development of 
seborrheic dermatitis as genetic predisposition, the role 
of microbial agents, immune and endocrine disorders, 
pathological conditions of autonomic nervous system, 
gastrointestinal tract pathology, lipid metabolism 
disorders etc. are presented [1, 5, 7, 13]. 
One of the main pathogenetic mechanisms of 
seborrheic dermatitis is the Malassezia activation 
with the formation of complex microbial asso-
ciations. Malassezia is a formation leader of fungi 
and microorganisms associations in the lesions with 
seborrheic dermatitis. Malassezia, in association 
with other bacteria, acquires an increased intrinsic 
virulence, which contributes to the increased 
virulence of other microorganisms. Formed fungi 
and microorganisms associations lead to an 
inflammatory process with the formation of various 
clinical manifestations of seborrheic dermatitis. The 
activation of opportunistic pathogenic microorga-
nisms on the skin in seborrheic dermatitis is 
evidenced by the higher contamination frequency of 
the affected scalp areas with S. capitis, Micrococcus 
spp., Acinetobacter spp. etc. [6, 8, 9, 10]. 
Therefore, local treatment of seborrheic derma-
titis should be directed to the use of dosage forms 
with antifungal and anti-inflammatory properties. 
Complex treatment of seborrheic dermatitis should 
be aimed at eliminating disease signs, eliminating 
concomitant symptoms, especially patient's subjec-
tive feelings and maintaining long-term remission 
[4, 8, 11]. 
In this work, we set the following purpose: to 
evaluate the efficacy and tolerance of an extemporal 
dosage form with pyroctone olamine for the local 
treatment of patients with seborrheic dermatitis. 
MATERIALS AND METHODS OF RESEARCH 
Under our supervision there were 78 patients 
with seborrheic dermatitis aged 18 to 57 years. The 
average age of the patients was 29.5 years. Among 
the examined patients with seborrheic dermatitis, 
there were 53 men (67.9%), 25 women (32.1%).  
The pathological process was localized only on 
hairy part of the scalp in 43 (55.1%) patients 
observed, and in 35 (44.9%) patients seborrheic 
process also spread to other skin areas. The duration 
of the disease ranged from 1 to 15 years. 
All patients with seborrheic dermatitis, who were 
under our supervision, underwent the following 
examination methods: carefully collected disease 
anamnesis with taking into account patient's su-
bjective feelings, skin examination, general and 
biochemical blood tests, general urinalysis [4].  
The material for microscopic and bacteriological 
methods of the study were swabbings from the 
affected areas of the skin of patients with seborrheic 
dermatitis. 
Patients were consulted by doctors of related 
specialties with the implementation of advisory 
recommendations. 
The patients were divided into two similar 
groups – the main and the control. 
The complex treatment of patients with sebor-
rheic dermatitis in both groups depended on the 
severity of clinical manifestations, the disease dura-
tion, and information about the effectiveness of 
previous therapy. Antihistamines were prescribed 
for severe itching. 
Local treatment in the comparison group con-
sisted of the appointment of 1% clotrimazole cream. 
For external treatment of the main group patients 
with seborrheic dermatitis, an extemporaneously 
prepared gel was used. The gel contains: pyroctone 
olamine (octopyrox) 1.0; demineralized naftalan 5.0; 
sodium carboxymethyl cellulose 3.0; glycerol 10.0; 
propylene glycol 20.0; tween 80 2.0; water (purified) 
up to 100.0 [8]. 
 
МЕДИЧНІ ПЕРСПЕКТИВИ / MEDICNI PERSPEKTIVI 
 19321/ Том XXVI / 1 
The analysis of the data received was carried out 
with application of the program product Statistica 6.1. 
(StatSoftInc., serial N AGAR909E415822FA). The 
difference in indices with p˂0.05 considered as 
probable one. To identify the relationships between 
the indices, Friedman's nonparametric variance 
analysis with the definition of χ2 was used. The 
coupling between indices was considered significant 
if χ2 value exceeded the critical one (χ2=3.84) [2, 3]. 
RESULTS AND DISCUSSION 
Among the examined patients with seborrheic 
dermatitis, in 45 (57.7%) patients oily seborrhea was 
revealed. 
A mixed form of seborrheic dermatitis was 
revealed in 23 (29.5%) patients. It manifested itself 
in a moderate sebum secretion increase on the face 
and skin of  the trunk with the appearance of 
separate comedones and acne-like rashes. 
The dry form of seborrheic dermatitis was in 10 
(12.8%) patients under our supervision. A dry form 
of seborrheic dermatitis was characterized by a 
sebum secretion decrease and the presence of scales 
of a different size and number. Most often, the 
pathological condition was developed in the occi-
pital-temporal area, then it spread to the entire scalp 
surface. In our opinion, the low frequency of dry 
form of seborrheic dermatitis is due to the fact that pa-
tients with an insignificant clinical manifestation of the 
disease very rarely seek specialized medical care. 
In most of the patients observed, a combination 
of several factors was established, such as the 
presence of foci of chronic infection, hormonal 
disorders (especially changes in the physiological 
balance of estrogens and androgens), vegetative-
dystonic dysfunction, changes in the enzymatic 
activity of the organs of the gastrointestinal tract and 
liver, this creates conditions for which the body 
loses the ability to control the reproduction of yeast-
like fungi and their virulence. 
Seborrheic dermatitis most often begins during 
puberty. Dermatitis had a long course with frequent 
relapses, mainly in the autumn-winter period and 
was associated with the diet disorder. The duration 
of the dermatosis course in 29 cases (37.2%) was up 
to 6 years. In 49 (62.8%) patients observed, the 
seborrheic dermatitis course was more than 6 years. 
The disease occurence in 45 (57.7%) patients was 
associated with the onset of puberty. We could not 
indicate the cause of dermatosis in 33 (42.3%) 
patients. The patients described the disease occur-
rence as an increased skin oiliness and the periodic 
appearance of inflammatory elements in the 
seborrheic zones. The exacerbation of the patho-
logical process was associated with the cold season 
as well as non-compliance with the diet or with the 
nutrition peculiarities. A small amount of women 
observed associated the first manifestations of sebor-
rheic dermatitis with the menstrual cycle formation. 
Bacteriological and microscopic examination of 
the sampling material from the affected skin areas of 
seborrheic dermatitis patients revealed Malassezia 
spp. in 69 cases (88.5%). 
The highest density of yeast-like fungi was on the 
skin in areas rich in sebaceous glands. These include 
the scalp, face, periauricular area, central areas of 
chest and back, genital area. Malassezia fungi prefer 
to colonize these areas due to their lipophilic 
properties. The Malassezia furfur species is unable 
to synthesize lipids, it needs an exogenous source of 
fatty acids, which are important both as an energy 
source and for metabolic processes, in particular 
membrane synthesis. The presence of saturated and 
unsaturated free fatty acids is necessary for the 
yeast-like Malassezia fungi full functioning. The 
main source of lipids for Malassezia spp. on human 
skin are triglycerides and free fatty acids produced 
by the sebaceous glands as well as cholesterol and 
cholesterol esters obtained in the process of kera-
tinization and corneocytes destruction. 
Among the causal mechanisms for the develop-
ment of seborrheic dermatitis, an important role is 
played by the reproduction of opportunistic microor-
ganisms against the background of an altered normal 
microbial biocenosis of the skin. 
Among other microorganisms that were iden-
tified during the examination of our patients, one 
should point out: St. Capitis at 54 (79.5%), St. 
Epidermidis – 42 (53.8%), Micrococcus spp. 23 
(29.5%), Acinetobacter spp. 12 (15.4%). St. Aureus, 
St. Capitis, St. Hominis, St. cohnii, St. Xylosus in 
the affected areas were found less (Fig. 1). 
The complex treatment of most of the patients we 
observed was well tolerated. Adverse reactions were 
observed only in three patients with seborrheic 
dermatitis. Thus, two patients after applying 1% 
clotrimazole cream and one more after applying 
extemporal gel complained of the appearance of 
feeling of constriction and insignificant subjective 
sensations (of an indefinite nature) at the site of 
application of the local dosage form. The adverse 
reaction was unstable and resolved within 15-20 
minutes without prescribing additional treatment. In 
the course of the treatment, there was a positive 
trend in the development of the pathological con-
dition. However, a more pronounced therapeutic 
effect was found with the prescribing of an extem-
poral gel. Among the patients of the main group, the 
period of clinical manifestations resolution was by 
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Fig. 1. The frequency of detecting microorganisms in microbiological examinations (%) 
 
Microscopic and bacteriological detection of 
Malassezia spp. from the affected skin areas of 
seborrheic dermatitis patients after local treatment 
was higher among patients of the comparison group. 
Thus, Malassezia spp. was found in 2 (5.1%) pa-
tients of the main and 9 (23.1%) of the control 
group. After the therapy of the affected skin areas, 
other microorganisms were detected in 12 (15.4%) 
patients of the comparison and in 3 (3.9%) patients 
of the main group. 
Long-term results of the study have shown that 
the disease recurrence among patients of the main 
group was in 5 cases (6.4%), among patients in the 
comparison group – in 14 (17.9%) (Fig. 2). 
 
 
Fig. 2. Results of complex treatment of patients with seborrheic dermatitis (%) 
% 
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Thus, the ongoing clinical study on the efficacy and 
tolerance of the extemporal gel for the local treatment 
of patients with seborrheic dermatitis has shown a 
good therapeutic effect, along with a good tolerance, in 
the complex treatment of the observed patients. 
CONCLUSIONS 
Considering a good therapeutic efficacy and tole-
rance of the extemporal gel with pyroctone olamine 
in the complex treatment of patients with seborrheic 
dermatitis gives a good reason to recommend this 
dosage form for wider use in the practice of derma-
tovenerologists. 
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